1030399

Astellas Pharma US Inc. — FEI 1000036852

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 1, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Northbrook, IL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)